(Q38547813)

4 September 2017

1 reference

title

Circulating tumor cells in breast cancer beyond the genotype of primary tumor for tailored therapy (English)

1 reference

4 September 2017

Chuanli Ren

1

1 reference

4 September 2017

Chongxu Han

2

1 reference

4 September 2017

Deyuan Fu

3

1 reference

4 September 2017

Daxin Wang

4

1 reference

4 September 2017

Hui Chen

5

1 reference

4 September 2017

Yong Chen

6

1 reference

4 September 2017

Ming Shen

7

1 reference

4 September 2017

language of work or name

English

0 references

publication date

14 July 2015

1 reference

International Journal of Cancer

4 September 2017

1 reference

4 September 2017

138

1 reference

4 September 2017

7

1 reference

4 September 2017

1586-1600

1 reference

4 September 2017

Cancer statistics, 2014

1 reference

Detection, clinical relevance and specific biological properties of disseminating tumour cells

21 January 2018

1 reference

Circulating tumor cells: a multifunctional biomarker

21 January 2018

1 reference

Circulating tumor cells predict survival in early average-to-high risk breast cancer patients

21 January 2018

1 reference

Ex Vivo Culture of CTCs: An Emerging Resource to Guide Cancer Therapy

21 January 2018

1 reference

Cancer therapy. Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility.

21 January 2018

1 reference

The biology of circulating tumor cells

21 January 2018

1 reference

Circulating breast cancer cells are frequently apoptotic

21 January 2018

1 reference

Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis

21 January 2018

1 reference

Apoptotic circulating tumor cells in early and metastatic breast cancer patients

21 January 2018

1 reference

Detection of apoptotic circulating tumor cells in advanced pancreatic cancer following 5-fluorouracil chemotherapy

21 January 2018

1 reference

Co-expression of MET and CD47 is a novel prognosticator for survival of luminal breast cancer patients

21 January 2018

1 reference

The identification and characterization of breast cancer CTCs competent for brain metastasis

21 January 2018

1 reference

Breast cancer metastasis suppressor-1 promoter methylation in primary breast tumors and corresponding circulating tumor cells

21 January 2018

1 reference

Circulating tumor cells: liquid biopsy of cancer

21 January 2018

1 reference

Circulating tumor cells and circulating tumor DNA.

21 January 2018

1 reference

Negative enrichment by immunomagnetic nanobeads for unbiased characterization of circulating tumor cells from peripheral blood of cancer patients

21 January 2018

1 reference

Determination of EGFR mutations in single cells microdissected from enriched lung tumor cells in peripheral blood.

21 January 2018

1 reference

The advantage of circulating tumor cells over serum carcinoembryonic antigen for predicting treatment responses in rectal cancer.

21 January 2018

1 reference

Microfluidic, marker-free isolation of circulating tumor cells from blood samples

21 January 2018

1 reference

Circulating tumor cell detection using a parallel flow micro-aperture chip system

21 January 2018

1 reference

A novel detection strategy for living circulating tumor cells using 5-aminolevulinic acid

21 January 2018

1 reference

Challenges in circulating tumour cell research

21 January 2018

1 reference

EPISPOT assay: detection of viable DTCs/CTCs in solid tumor patients

21 January 2018

1 reference

Detection of circulating tumour cells in peripheral blood with an automated scanning fluorescence microscope

21 January 2018

1 reference

The epithelial-mesenchymal transition generates cells with properties of stem cells

21 January 2018

1 reference

Circulating tumor cells as early predictors of metastatic spread in breast cancer patients with limited metastatic dissemination

21 January 2018

1 reference

Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases

21 January 2018

1 reference

Circulating tumor cells in non-metastatic triple-negative breast cancer

21 January 2018

1 reference

Final results of a phase II study of paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer.

21 January 2018

1 reference

Serial enumeration of circulating tumor cells predicts treatment response and prognosis in metastatic breast cancer: a prospective study in 393 patients

21 January 2018

1 reference

Circulating tumor cells and response to chemotherapy in metastatic breast cancer: SWOG S0500

21 January 2018

1 reference

International study on inter-reader variability for circulating tumor cells in breast cancer

21 January 2018

1 reference

Isolating highly enriched populations of circulating epithelial cells and other rare cells from blood using a magnetic sweeper device

21 January 2018

1 reference

Prognostic impact of circulating tumor cells assessed with the CellSearch System™ and AdnaTest Breast™ in metastatic breast cancer patients: the DETECT study

21 January 2018

1 reference

Mesenchymal phenotype of CTC-enriched blood fraction and lymph node metastasis formation potential.

21 January 2018

1 reference

Detection of circulating tumor cells during follow-up of patients with early breast cancer: Clinical utility for monitoring of therapy efficacy.

21 January 2018

1 reference

Detection of circulating tumor cells in blood of metastatic breast cancer patients using a combination of cytokeratin and EpCAM antibodies

21 January 2018

1 reference

Considerations in the development of circulating tumor cell technology for clinical use

21 January 2018

1 reference

Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients.

21 January 2018

1 reference

CD49f-based selection of circulating tumor cells (CTCs) improves detection across breast cancer subtypes

21 January 2018

1 reference

EMT and EGFR in CTCs cytokeratin negative non-metastatic breast cancer

21 January 2018

1 reference

SSA-MOA: a novel CTC isolation platform using selective size amplification (SSA) and a multi-obstacle architecture (MOA) filter

21 January 2018

1 reference

Isolation of rare circulating tumour cells in cancer patients by microchip technology

21 January 2018

1 reference

Sensitive capture of circulating tumour cells by functionalized graphene oxide nanosheets

21 January 2018

1 reference

Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay

21 January 2018

1 reference

Drug response of captured BT20 cells and evaluation of circulating tumor cells on a silicon nanowire platform

21 January 2018

1 reference

Enrichment and enumeration of circulating tumor cells by efficient depletion of leukocyte fractions

21 January 2018

1 reference

Heterogeneous atypical cell populations are present in blood of metastatic breast cancer patients.

21 January 2018

1 reference

Negative enrichment of circulating tumor cells using a geometrically activated surface interaction chip

21 January 2018

1 reference

Clinical validation of an ultra high-throughput spiral microfluidics for the detection and enrichment of viable circulating tumor cells

21 January 2018

1 reference

A microchip filter device incorporating slit arrays and 3-D flow for detection of circulating tumor cells using CAV1-EpCAM conjugated microbeads

21 January 2018

1 reference

A radial flow microfluidic device for ultra-high-throughput affinity-based isolation of circulating tumor cells

21 January 2018

1 reference

Flexible micro spring array device for high-throughput enrichment of viable circulating tumor cells

21 January 2018

1 reference

Microfluidic flow fractionation device for label-free isolation of circulating tumor cells (CTCs) from breast cancer patients

21 January 2018

1 reference

Development of a new rapid isolation device for circulating tumor cells (CTCs) using 3D palladium filter and its application for genetic analysis

21 January 2018

1 reference

Co-expression of putative stemness and epithelial-to-mesenchymal transition markers on single circulating tumour cells from patients with early and metastatic breast cancer

21 January 2018

1 reference

Quantification of the response of circulating epithelial cells to neodadjuvant treatment for breast cancer: a new tool for therapy monitoring

21 January 2018

1 reference

Microdevice for the isolation and enumeration of cancer cells from blood.

21 January 2018

1 reference

Isolation of breast cancer and gastric cancer circulating tumor cells by use of an anti HER2-based microfluidic device

21 January 2018

1 reference

A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas

21 January 2018

1 reference

Isolation by size of epithelial tumor cells in peripheral blood of patients with breast cancer: correlation with real-time reverse transcriptase-polymerase chain reaction results and feasibility of molecular analysis by laser microdissection

21 January 2018

1 reference

Portable filter-based microdevice for detection and characterization of circulating tumor cells

21 January 2018

1 reference

Isolation of tumor cells using size and deformation

21 January 2018

1 reference

A negative selection methodology using a microfluidic platform for the isolation and enumeration of circulating tumor cells

21 January 2018

1 reference

Prognostic relevance of viable circulating tumor cells detected by EPISPOT in metastatic breast cancer patients

21 January 2018

1 reference

Isolation of circulating epithelial and tumor progenitor cells with an invasive phenotype from breast cancer patients

21 January 2018

1 reference

Characterization of circulating tumor cell aggregates identified in patients with epithelial tumors.

21 January 2018

1 reference

Case study of the morphologic variation of circulating tumor cells.

21 January 2018

1 reference

Standardized quantification of circulating peripheral tumor cells from lung and breast cancer.

21 January 2018

1 reference

A rare-cell detector for cancer

21 January 2018

1 reference

Fluid biopsy in patients with metastatic prostate, pancreatic and breast cancers

21 January 2018

1 reference

A combined micromagnetic-microfluidic device for rapid capture and culture of rare circulating tumor cells

21 January 2018

1 reference

A novel approach using telomerase-specific replication-selective adenovirus for detection of circulating tumor cells in breast cancer patients

21 January 2018

1 reference

Slanted spiral microfluidics for the ultra-fast, label-free isolation of circulating tumor cells

21 January 2018

1 reference

Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition

21 January 2018

1 reference

Detection and molecular analysis of circulating tumor cells for early diagnosis of pancreatic cancer

21 January 2018

1 reference

Circulating tumor cells as promising novel biomarkers in solid cancers

21 January 2018

1 reference

Detection of circulating tumor cell-specific markers in breast cancer patients using the quantitative RT-PCR assay.

21 January 2018

1 reference

The biological and clinical importance of epithelial-mesenchymal transition in circulating tumor cells

21 January 2018

1 reference

Meta-analysis of the prognostic value of circulating tumor cells in breast cancer

21 January 2018

1 reference

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

21 January 2018

1 reference

Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data

21 January 2018

1 reference

Differential effect of adjuvant taxane-based and taxane-free chemotherapy regimens on the CK-19 mRNA-positive circulating tumour cells in patients with early breast cancer

21 January 2018

1 reference

The prognostic significance of tumour cell detection in the peripheral blood versus the bone marrow in 733 early-stage breast cancer patients

21 January 2018

1 reference

Detection of cytokeratin-19 mRNA-positive cells in the peripheral blood and bone marrow of patients with operable breast cancer

21 January 2018

1 reference

Cytokeratin-19 mRNA-positive circulating tumor cells after adjuvant chemotherapy in patients with early breast cancer.

21 January 2018

1 reference

Circulating tumor cell detection predicts early metastatic relapse after neoadjuvant chemotherapy in large operable and locally advanced breast cancer in a phase II randomized trial.

21 January 2018

1 reference

Circulating tumor cells, disease recurrence and survival in newly diagnosed breast cancer

21 January 2018

1 reference

Prognostic significance of occult tumor cells in the apheresis products of patients with advanced breast cancer receiving high-dose chemotherapy and autologous hematopoietic progenitor cell support

21 January 2018

1 reference

Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer

21 January 2018

1 reference

Detection of Mammaglobin A-mRNA-positive circulating tumor cells in peripheral blood of patients with operable breast cancer with nested RT-PCR.

21 January 2018

1 reference

Circulating tumor cells in immunohistochemical subtypes of metastatic breast cancer: lack of prediction in HER2-positive disease treated with targeted therapy.

21 January 2018

1 reference

The prognostic impact of circulating tumor cells in subtypes of metastatic breast cancer.

21 January 2018

1 reference

Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment

21 January 2018

1 reference

Circulating tumor cells versus imaging--predicting overall survival in metastatic breast cancer.

21 January 2018

1 reference

Cytokeratin-19 and mammaglobin gene expression in circulating tumor cells from metastatic breast cancer patients enrolled in North Central Cancer Treatment Group trials, N0234/336/436/437.

21 January 2018

1 reference

Variation of circulating tumor cell levels during treatment of metastatic breast cancer: prognostic and therapeutic implications

21 January 2018

1 reference

Circulating tumor cells: a useful predictor of treatment efficacy in metastatic breast cancer

21 January 2018

1 reference

Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapies

21 January 2018

1 reference

Detection and prognostic significance of circulating tumour cells in patients with metastatic breast cancer according to immunohistochemical subtypes

21 January 2018

1 reference

A multicenter phase I-II study of docetaxel plus epirubicin plus bevacizumab as first-line treatment in women with HER2-negative metastatic breast cancer

21 January 2018

1 reference

Circulating tumor cells predict progression-free and overall survival in Chinese patients with metastatic breast cancer, HER2-positive or triple-negative (CBCSG004): a multicenter, double-blind, prospective trial

21 January 2018

1 reference

Clinical relevance of circulating CK-19mRNA-positive tumour cells before front-line treatment in patients with metastatic breast cancer

21 January 2018

1 reference

Prognostic value of HER2-positive circulating tumor cells in patients with metastatic breast cancer.

21 January 2018

1 reference

Clinical implications of circulating tumor cells of breast cancer patients: role of epithelial-mesenchymal plasticity

21 January 2018

1 reference

Trastuzumab decreases the incidence of clinical relapses in patients with early breast cancer presenting chemotherapy-resistant CK-19mRNA-positive circulating tumor cells: results of a randomized phase II study.

21 January 2018

1 reference

HER-2 gene amplification can be acquired as breast cancer progresses

21 January 2018

1 reference

CD133 expression in circulating tumor cells from breast cancer patients: potential role in resistance to chemotherapy

21 January 2018

1 reference

Complex tumor genomes inferred from single circulating tumor cells by array-CGH and next-generation sequencing

21 January 2018

1 reference

The impact of HER2 phenotype of circulating tumor cells in metastatic breast cancer: a retrospective study in 107 patients

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.29679

1 reference

4 September 2017

1 reference